0000899243-19-026147.txt : 20191029 0000899243-19-026147.hdr.sgml : 20191029 20191029203145 ACCESSION NUMBER: 0000899243-19-026147 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180502 FILED AS OF DATE: 20191029 DATE AS OF CHANGE: 20191029 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee June CENTRAL INDEX KEY: 0001696493 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37609 FILM NUMBER: 191177134 MAIL ADDRESS: STREET 1: C/O MYOKARDIA, INC. STREET 2: 333 ALLERTON AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyoKardia Inc CENTRAL INDEX KEY: 0001552451 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455500552 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-741-0900 MAIL ADDRESS: STREET 1: 333 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-02 1 0001552451 MyoKardia Inc MYOK 0001696493 Lee June C/O MYOKARDIA, INC. 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP, Chief Development Officer Common Stock 2018-05-02 4 M 0 5457 11.95 A 9610 D Common Stock 2018-05-09 4 M 0 4500 11.95 A 14110 D Common Stock 2018-05-31 4 M 0 364 11.95 A 14474 D Common Stock 2018-07-10 4 M 0 364 11.95 A 14838 D Common Stock 2018-08-09 4 M 0 363 11.95 A 15201 D Common Stock 2018-09-04 4 M 0 364 11.95 A 15565 D Common Stock 2018-10-01 4 M 0 364 11.95 A 15929 D Common Stock 2018-10-11 4 M 0 2500 11.95 A 18429 D Common Stock 2018-11-06 4 M 0 364 11.95 A 18793 D Common Stock 2018-12-03 4 M 0 364 11.95 A 19157 D Common Stock 2019-02-25 4 M 0 3000 11.95 A 22157 D Stock Option (Right to Buy) 11.95 2018-05-02 4 M 0 5457 0.00 D 2027-01-31 Common Stock 5457 110160 D Stock Option (Right to Buy) 11.95 2018-05-09 4 M 0 4500 0.00 D 2027-01-31 Common Stock 4500 105660 D Stock Option (Right to Buy) 11.95 2018-05-31 4 M 0 364 0.00 D 2027-01-31 Common Stock 364 105296 D Stock Option (Right to Buy) 11.95 2018-07-10 4 M 0 364 0.00 D 2027-01-31 Common Stock 364 104932 D Stock Option (Right to Buy) 11.95 2018-08-09 4 M 0 363 0.00 D 2027-01-31 Common Stock 363 104569 D Stock Option (Right to Buy) 11.95 2018-09-04 4 M 0 364 0.00 D 2027-01-31 Common Stock 364 104205 D Stock Option (Right to Buy) 11.95 2018-10-01 4 M 0 364 0.00 D 2027-01-31 Common Stock 364 103841 D Stock Option (Right to Buy) 11.95 2018-10-11 4 M 0 2500 0.00 D 2027-01-31 Common Stock 2500 101341 D Stock Option (Right to Buy) 11.95 2018-11-06 4 M 0 364 0.00 D 2027-01-31 Common Stock 364 100977 D Stock Option (Right to Buy) 11.95 2018-12-03 4 M 0 364 0.00 D 2027-01-31 Common Stock 364 100613 D Stock Option (Right to Buy) 11.95 2019-02-25 4 M 0 3000 0.00 D 2018-06-28 2027-01-31 Common Stock 3000 3250 D 25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date. On February 1, 2017, the Reporting Person was granted an option to purchase 25,000 shares of Common Stock under the issuer's 2015 Equity Incentive Plan, the vesting of which was subject to various conditions (other than the passage of time and continued employment) that were not tied to the market price of the issuer's securities. On June 28, 2018, one of the conditions was deemed to be achieved, resulting in the vesting and exercisability of 6,250 of the shares underlying such option. /s/ Cynthia J. Ladd, as Attorney-in-Fact 2019-10-29